List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 125 studies with search of:   "Polycythemia"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes
Conditions: Polycythemia Vera;   Essential Thrombocythemia;   Myelofibrosis
Intervention:
2 Recruiting Dastinib in Polycythemia Vera
Condition: Polycythemia Vera
Intervention: Drug: Dasatinib
3 Active, not recruiting Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia Vera
Condition: Polycythemia Vera
Intervention: Drug: pegylated interferon-alfa 2a
4 Recruiting A Phase 1 Study of XL019 in Adults With Polycythemia Vera
Condition: Polycythemia Vera
Intervention: Drug: XL019
5 Recruiting Molecular Biology of Polycythemia
Condition: Primary Familial and Congenital Polycythemia
Intervention:
6 Not yet recruiting Treatment of High Altitude Polycythemia by Acetazolamide
Condition: High Altitude Polycythemia
Intervention: Drug: acetazolamide
7 Recruiting Effects of Imatinib Mesylate in Polycythemia Vera
Condition: Polycythemia Vera
Intervention: Drug: Imatinib Mesylate
8 Recruiting Study to Determine the Safety and Efficacy of INCB018424 in Patients With Polycythemia Vera or Essential Thrombocythemia
Conditions: Polycythemia Vera;   Essential Thrombocythemia
Interventions: Drug: INCB018424;   Drug: INCB018424;   Drug: INCB018424
9 Recruiting Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis
Conditions: Polycythemia Vera;   Essential Thrombocytosis
Intervention: Drug: lestaurtinib
10 Recruiting Open Label INCB018424 in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis
Conditions: Myelofibrosis;   Polycythemia Vera;   Thrombocytosis
Intervention:
11 Recruiting Therapy of HES, PV, Atypical CML or CMML, and Mastocytosis With Imatinib Mesylate
Conditions: Chronic Myelomonocytic Leukemia;   Chronic Myeloid Leukemia;   Polycythemia Vera;   Hypereosinophilic Syndrome;   Mastocytosis
Intervention: Drug: Imatinib Mesylate (Gleevec)
12 Active, not recruiting Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)
Conditions: Acute Myeloid Leukemia;   Myelodysplastic Syndromes;   Agnogenic Myeloid Metaplasia;   Myelofibrosis;   Hypereosinophilic Syndrome;   Polycythemia Vera;   Mastocytosis;   Leukemia, Myelomonocytic, Chronic
Intervention: Drug: Dasatinib (BMS-354825)
13 Recruiting Gene Changes and Biomarkers in Chronic Myeloproliferative Disorders
Conditions: Polycythemia Vera;   Essential Thrombocytosis;   Idiopathic Myelofibrosis;   Neutrophils;   Chronic Myeloproliferative Disorders
Intervention:
14 Recruiting CEP-701 (Lestaurtinib) in Myelofibrosis
Conditions: Myelofibrosis;   Essential Thrombocythemia;   Polycythemia Vera
Intervention: Drug: CEP-701 (Lestaurtinib)
15 Recruiting Research Tissue Bank
Conditions: Myelofibrosis;   Idiopathic Myelofibrosis;   Essential Thrombocythemia;   Polycythemia Vera
Intervention:
16 Recruiting A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis
Conditions: Myelofibrosis;   Myeloproliferative Disorders;   Polycythemia Vera;   Essential Thrombocythemia
Intervention: Drug: SB1518
17 Recruiting Correlative Biomarker Study in Patients With Myeloproliferative Disorders
Conditions: Myeloproliferative Disease;   Myelofibrosis;   Idiopathic Myelofibrosis;   Essential Thrombocythemia;   Polycythemia Vera
Intervention:
18 Recruiting Familial Myeloproliferative Disorders
Conditions: Polycythemia Vera;   Essential Thrombocythemia;   Idiopathic Myelofibrosis
Intervention:
19 Recruiting Pulmonary Hypertension, Hypoxia and Sickle Cell Disease
Conditions: Chuvash Polycythemia;   Cerebrovascular Disease;   Pulmonary Hypertension;   Sickle Cell Anemia
Intervention:
20 Not yet recruiting A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies
Conditions: Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia;   Chronic Myelogenous Leukemia;   Chronic Lymphocytic Leukemia;   Multiple Myeloma;   Waldenstrom's Macroglobulinemia;   Myelodysplastic Syndrome;   Philadelphia Chromosome-Negative CML;   Myeloid Metaplasia;   Myelofibrosis;   Advanced Polycythemia;   Non-Hodgkins Lymphoma
Intervention: Drug: TAK-901

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services